This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bagg, J Articles by McHugh, S Search for Related Content PubMed PubMed Citation Articles by Bagg, J Articles by McHugh, S Social Bookmarking                         What's this?

High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer

M P Sweeney

Glasgow Dental Hospital and School, University of Glasgow, Glasgow

M AO Lewis

Dental School, University of Wales College of Medicine, Cardiff

M S Jackson

Glasgow Dental Hospital and School, University of Glasgow, Glasgow

D Coleman

A Al Mosaid

Dublin Dental School and Hospital, University of Dublin, Dublin

W Baxter

ACCORD Hospice, Paisley

S McEndrick

Prince & Princess of Wales Hospice, Glasgow

S McHugh

Glasgow Dental Hospital and School, University of Glasgow, Glasgow

Oral fungal infections frequently develop in individuals with advanced cancer. This study examined the oral mycological flora of 207 patients receiving palliative care for advanced malignant disease. Demographic details and a clinical history were documented from each participant. A tongue swab was collected and cultured on CHROMAgar Candida^® (CHROMAgar Paris, France). All yeasts were identified by germ tube test, API ID 32C profiles and, for Candida dubliniensis, by species-specific PCR. Susceptibility to fluconazole and itraconazole was determined by a broth microdilution assay according to the National Committee for Clinical Laboratory Standards (NCCLS). At time of sampling, 54 (26%) of the 207 subjects had clinical evidence of a fungal infection and yeasts were isolated from 139 (67%) individuals. In total, 194 yeasts were isolated, of which 95 (49%) were Candida albicans. There was a high prevalence of Candidia glabrata (47 isolates) of which 34 (72%) were resistant to both fluconazole and itraconazole. All nine isolates of C. dubliniensis recovered were susceptible to both azoles. No relationship was established between anti-fungal usage in the preceding three months and the presence of azole resistant yeasts. This study of patients with advanced cancer has demonstrated a high incidence of oral colonization with non-C. albicans yeasts, many of which had reduced susceptibility to fluconazole and itraconazole. The role of improved oral care regimes and novel anti-fungal drugs merits further attention, to reduce the occurrence of fungal infection in these patients.

Key Words: azole anti-fungals • Candida spp • oral health • palliative care

Palliative Medicine, Vol. 17, No. 6, 477-481 (2003)
DOI: 10.1191/0269216303pm793oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Li, S. Redding, and A. Dongari-Bagtzoglou Candida glabrata, an Emerging Oral Opportunistic Pathogen Journal of Dental Research, March 1, 2007; 86(3): 204 - 215. [Abstract] [Full Text] [PDF]

				R. Rautemaa, P. Rusanen, M. Richardson, and J. H. Meurman Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J. Med. Microbiol., October 1, 2006; 55(Pt 10): 1447 - 1451. [Abstract] [Full Text] [PDF]

				J. Bagg, M P. Sweeney, A. N Davies, M. S Jackson, and S. Brailsford Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer J. Med. Microbiol., October 1, 2005; 54(10): 959 - 964. [Abstract] [Full Text] [PDF]

				A. Al Mosaid, D. J. Sullivan, I. Polacheck, F. A. Shaheen, O. Soliman, S. Al Hedaithy, S. Al Thawad, M. Kabadaya, and D. C. Coleman Novel 5-Flucytosine-Resistant Clade of Candida dubliniensis from Saudi Arabia and Egypt Identified by Cd25 Fingerprinting J. Clin. Microbiol., August 1, 2005; 43(8): 4026 - 4036. [Abstract] [Full Text] [PDF]